Research Antibodies Market Players:
- F. Hoffman- La Roche AG
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Merck & Co., Inc.
- Eli Lilly Company
- AstraZeneca
- Thermo Fisher Scientific, Inc.
- Abcam Plc
- PerkinElmer
- BGI Group
- Jackson ImmunoResearch Inc.
- Junshi Biosciences
The research antibodies market is competitive with the presence of global and regional players and new players venturing in for the market share. The significant growth potential is owed to the rapid advancements in biotechnology globally along with rising demand for precision medicines.
Some of the key players in the market are:
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of research antibodies is assessed at USD 1.82 billion.
The global research antibodies market size was valued at over USD 1.74 billion in 2025 and is expected to register a CAGR of around 4.9%, exceeding USD 2.81 billion revenue by 2035.
North America research antibodies market will account for 40.70% share by 2035, driven by robust technological infrastructure, increasing government investment in R&D, and strong regulatory frameworks.
Key players in the market include F. Hoffman La Roche AG, Merck & Co., Inc., AstraZeneca, Eli Lilly Company, Thermo Fisher Scientific, Abcam Plc, Immuno Biological Laboratories Co., MBL Life Sciences, PerkinElmer.
